Patents by Inventor Guangrong Tang

Guangrong Tang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND SYSTEM BASED ON MATRIX CHECK FOR RAPIDLY DETERMINING RATIONAL USE OF MEDICINE
    Publication number: 20230207086
    Abstract: A method and a system based on matrix check for rapidly determining rational use of a medicine are provided. Attribute values of a medicine are established. The medicine attribute values are added to nodes starting from a root node. A range of attribute values is set, to obtain a determination standard for the attribute values. Data in a tree structure is obtained, and then is split according to different dimensions. A value is defined for each of the different dimensions. The tree structure is traversed to obtain values of each two attributes in the different dimensions. The obtained values of different dimensions are marked as subscripts of a multi-dimensional array. A check matrix is constructed by using the multi-dimensional array. A value of an element in the check matrix is extracted. A conclusion about rational use of the medicine is outputted based on the value of the obtained element.
    Type: Application
    Filed: October 24, 2022
    Publication date: June 29, 2023
    Applicants: HOSPITAL OF CHENGDU OFFICE OF PEOPLE?S GOVERNMENT OF TIBETAN AUTONOMOUS REGION (HOSPITAL.C.T.), MEDISOFTWARE CO., LTD.
    Inventors: Xiaosi LI, Yihong XIE, Yong CHEN, Yuru HE, Shu ZHANG, Guangrong TANG, Rongcier LU
  • Substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic acids and amides and methods of making the same
    Patent number: 10100035
    Abstract: The present invention relates to certain intermediates useful in the preparation of certain benzoimidazol-2-yl pyrimidines and processes for preparing them.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: October 16, 2018
    Assignee: Janssen Pharmaceutica NV
    Inventors: Diego Broggini, Matteo Conza, Oliver Flögel, Stefan Horns, Susanne Lochner, Guangrong Tang, Zhaobin Wang, Lucie Lovelle
  • SUBSTITUTED 2-[3-(1-METHYL-PIPERIDIN-4-YL)-PROPYLAMINO]-PYRIMIDINE-5-CARBOXYLIC ACIDS AND AMIDES AND METHODS OF MAKING THE SAME
    Publication number: 20180009783
    Abstract: The present invention relates to certain intermediates useful in the preparation of certain benzoimidazol-2-yl pyrimidines and processes for preparing them.
    Type: Application
    Filed: September 20, 2017
    Publication date: January 11, 2018
    Inventors: Diego Broggini, Matteo Conza, Oliver Flögel, Stefan Horns, Susanne Lochner, Guangrong Tang, Zhaobin Wang, Lucie Lovelle
  • Substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic acids and amides and methods of making the same
    Patent number: 9796699
    Abstract: The present invention relates to certain intermediates useful in the preparation of certain benzoimidazol-2-yl pyrimidines and processes for preparing them.
    Type: Grant
    Filed: November 2, 2016
    Date of Patent: October 24, 2017
    Assignee: Janssen Pharmaceutica NV
    Inventors: Diego Broggini, Matteo Conza, Oliver Flögel, Stefan Horns, Susanne Lochner, Guangrong Tang, Zhaobin Wang, Lucie Lovelle
  • SUBSTITUTED 2-[3-(1-METHYL-PIPERIDIN-4-YL)-PROPYLAMINO]-PYRIMIDINE-5-CARBOXYLIC ACIDS AND AMIDES AND METHODS OF MAKING THE SAME
    Publication number: 20170121309
    Abstract: The present invention relates to certain intermediates useful in the preparation of certain benzoimidazol-2-yl pyrimidines and processes for preparing them.
    Type: Application
    Filed: November 2, 2016
    Publication date: May 4, 2017
    Inventors: Diego Broggini, Matteo Conza, Oliver Flögel, Stefan Horns, Susanne Lochner, Guangrong Tang, Zhaobin Wang, Lucie Lovelle